2016-03-07T00:00:00.000-05:00
short-term price movements,-0.445273
small cap drug,-0.562894
Wall Street,-0.599544
long term,-0.445273
diverse range,0.52021
disclosure policy,-0.438396
clinical stage biopharma,-0.391551
Motley Fool,-0.471638
Adamas Pharmaceuticals,0.565309
market noise,-0.847082
fourth-quarter earnings,-0.564227
levodopa-induced dyskinesia,-0.737045
Net loss,-0.508576
regulatory approval process,-0.445273
CEO Gregory Went,-0.737045
biopharma stocks.Intra-Cellular Therapies,-0.460663
lead compound ADS-5102,-0.737045
Brian Feroldi,-0.37236
New Drug Application,-0.737045
earnings release Adamas,-0.737045
company,-0.590649
line results,0.565309
potential treatment,-0.737045
better investors,0.52021
quarter earnings,0.565309
share price drop,-0.847082
Foolish newsletter services,-0.240471
